Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shiqin Hong
Institutions:
Zhejiang Provincial People's Hospital,
Hangzhou Medical College
Observed institutions:
Zhejiang Provincial People's Hospital,
Hangzhou Medical College
ORCID:
0009-0002-1889-5490
Observed ORCID:
0009-0002-1889-5490
OpenAlex ID:
A5125460349
Androgen Receptor Signaling Induces CD8+ T-cell Dysfunction That Is Reversed by Androgen Deprivation Therapy in Male Head and Neck Squamous Cell Carcinoma
2026
·
Qiyue Wang
, Zhuo Tan
, et al.
·
Cancer Research
·
5
Figure S4 from Androgen Receptor Signaling Induces CD8+ T-cell Dysfunction That Is Reversed by Androgen Deprivation Therapy in Male Head and Neck Squamous Cell Carcinoma
2026
·
Qiyue Wang
, Zhuo Tan
, et al.
Figure S10 from Androgen Receptor Signaling Induces CD8+ T-cell Dysfunction That Is Reversed by Androgen Deprivation Therapy in Male Head and Neck Squamous Cell Carcinoma
2026
·
Qiyue Wang
, Zhuo Tan
, et al.
Figure S8 from Androgen Receptor Signaling Induces CD8+ T-cell Dysfunction That Is Reversed by Androgen Deprivation Therapy in Male Head and Neck Squamous Cell Carcinoma
2026
·
Qiyue Wang
, Zhuo Tan
, et al.
Data from Androgen Receptor Signaling Induces CD8+ T-cell Dysfunction That Is Reversed by Androgen Deprivation Therapy in Male Head and Neck Squamous Cell Carcinoma
2026
·
Qiyue Wang
, Zhuo Tan
, et al.
Table S2 from Androgen Receptor Signaling Induces CD8+ T-cell Dysfunction That Is Reversed by Androgen Deprivation Therapy in Male Head and Neck Squamous Cell Carcinoma
2026
·
Qiyue Wang
, Zhuo Tan
, et al.
Figure S2 from Androgen Receptor Signaling Induces CD8+ T-cell Dysfunction That Is Reversed by Androgen Deprivation Therapy in Male Head and Neck Squamous Cell Carcinoma
2026
·
Qiyue Wang
, Zhuo Tan
, et al.
Figure S1 from Androgen Receptor Signaling Induces CD8+ T-cell Dysfunction That Is Reversed by Androgen Deprivation Therapy in Male Head and Neck Squamous Cell Carcinoma
2026
·
Qiyue Wang
, Zhuo Tan
, et al.
Table S3 from Androgen Receptor Signaling Induces CD8+ T-cell Dysfunction That Is Reversed by Androgen Deprivation Therapy in Male Head and Neck Squamous Cell Carcinoma
2026
·
Qiyue Wang
, Zhuo Tan
, et al.
Table S1 from Androgen Receptor Signaling Induces CD8+ T-cell Dysfunction That Is Reversed by Androgen Deprivation Therapy in Male Head and Neck Squamous Cell Carcinoma
2026
·
Qiyue Wang
, Zhuo Tan
, et al.
Figure S6 from Androgen Receptor Signaling Induces CD8+ T-cell Dysfunction That Is Reversed by Androgen Deprivation Therapy in Male Head and Neck Squamous Cell Carcinoma
2026
·
Qiyue Wang
, Zhuo Tan
, et al.
Figure S9 from Androgen Receptor Signaling Induces CD8+ T-cell Dysfunction That Is Reversed by Androgen Deprivation Therapy in Male Head and Neck Squamous Cell Carcinoma
2026
·
Qiyue Wang
, Zhuo Tan
, et al.
Figure S7 from Androgen Receptor Signaling Induces CD8+ T-cell Dysfunction That Is Reversed by Androgen Deprivation Therapy in Male Head and Neck Squamous Cell Carcinoma
2026
·
Qiyue Wang
, Zhuo Tan
, et al.
Figure S3 from Androgen Receptor Signaling Induces CD8+ T-cell Dysfunction That Is Reversed by Androgen Deprivation Therapy in Male Head and Neck Squamous Cell Carcinoma
2026
·
Qiyue Wang
, Zhuo Tan
, et al.
Figure S5 from Androgen Receptor Signaling Induces CD8+ T-cell Dysfunction That Is Reversed by Androgen Deprivation Therapy in Male Head and Neck Squamous Cell Carcinoma
2026
·
Qiyue Wang
, Zhuo Tan
, et al.
Show more works
View as search
Works count:
15
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type